What Clinical Endpoints Should Practitioners Monitor When Operating A Co2 Medical Aesthetic Laser System To Ensure Safety And Prevent Tissue Scarring? Key Safety Endpoints Explained

The key safety endpoint is controlled depth, not maximum visible ablation. During ablative CO₂ resurfacing, practitioners should monitor tissue appearance after each pass and stop when the target is adequately corrected, tissue becomes visibly desiccated, or a faint chamois-yellow color appears. This color change signals that treatment is approaching the reticular dermis, where additional thermal injury substantially increases the risk of hypertrophic or atrophic scarring.

Stop treatment at the earliest meaningful endpoint. The safest endpoint is the first occurrence of adequate target correction, visible desiccation, loss of further tightening, the prescribed pass limit, or faint persistent yellowing after gentle cleansing.

What the Operator Should Monitor

Target correction or wrinkle disappearance

Treatment should stop when the targeted wrinkle, scar edge, lesion, or irregularity has been sufficiently flattened or visually corrected. Additional passes after complete correction add thermal injury without a corresponding cosmetic benefit.

This endpoint must be assessed under appropriate lighting and magnification, particularly when treating contours, eyelids, perioral skin, or scar borders.

Visible tissue desiccation

A dry, desiccated appearance indicates that effective vaporization has transitioned toward thermal coagulation. This is a warning that further passes may increase residual thermal damage rather than improve ablation.

Treatment should stop when desiccation is observed, even if the desired endpoint has not been reached uniformly across the entire field. The operator should reassess the treatment plan rather than continue indiscriminately.

Faint chamois-yellow coloration

A faint chamois-like yellow hue is a critical depth endpoint. It indicates that ablation has approached the deeper dermis, including the reticular dermis, where the risk of scarring rises sharply.

The appearance should be evaluated after char and debris are gently removed with saline-moistened gauze. Continuing to laser through this endpoint can cause excessive coagulation, delayed healing, tissue sloughing, and hypertrophic scarring.

Cessation of visible thermal contraction

Early treatment may produce visible skin tightening or contraction. When additional passes no longer produce meaningful tightening, continued exposure is unlikely to provide proportional benefit and may instead increase residual thermal damage.

This endpoint is especially useful when the surface appearance alone is difficult to interpret. It should be considered alongside tissue color, desiccation, target correction, and the planned pass limit.

Preset pass limit

Pass limits provide a procedural boundary against cumulative thermal injury. A commonly described sequence is:

First pass: epidermal removal.
Second pass: treatment extending into the upper papillary dermis.
Third pass: treatment approaching the mid-papillary dermis.

These are general treatment concepts, not universal rules. The appropriate number of passes depends on device settings, treatment density, tissue thickness, anatomical site, and the patient’s healing risk.

How to Interpret Tissue Between Passes

Clear the field before judging depth

Vaporized tissue and char should be removed between passes using sterile saline-moistened gauze, followed by gentle drying when appropriate. This restores visibility and prevents debris from obscuring the actual tissue endpoint.

Charred material can also retain heat and reduce the reliability of visual assessment. Operators should never use obscured tissue appearance as a reason to deliver another pass without first cleaning and reassessing the field.

Distinguish superficial yellowing from dangerous discoloration

A faint, early chamois-yellow appearance is a signal to stop because the treatment is nearing a high-risk depth. Persistent yellow-brown discoloration after cleansing is more concerning for substantial dermal thermal injury or necrosis.

Neither finding should be treated as a target to intensify. The appropriate response is to cease laser delivery, document the endpoint, and manage the wound according to the clinician’s established protocol.

Assess each anatomical region independently

Skin thickness varies considerably across the face and body. Thin eyelid, neck, and other anatomically sensitive areas generally tolerate less cumulative thermal exposure than thicker cheek or perioral skin.

A uniform pass count across all regions can therefore be unsafe. The operator should reassess color, desiccation, contraction, and target correction separately in each treatment zone.

Preventing Endpoint Overshoot

Avoid pulse stacking and excessive overlap

Repeated pulses in the same location and overlapping scanned patterns concentrate energy and enlarge the zone of residual thermal damage. Automated scanners should be aligned accurately, with minimal or no unintended overlap.

The goal is consistent energy distribution, not simply greater energy delivery. Localized overheating may not improve ablation depth but can prolong erythema and increase scarring risk.

Maintain controlled handpiece movement

Slow movement or excessive dwell time can create char and excessive coagulation. Operators should use the device’s validated technique and maintain a controlled, consistent delivery pattern appropriate to the selected mode.

Because a laser provides no tactile feedback like a scalpel, visual monitoring, magnification, and disciplined handpiece control are essential.

Do not treat char as a useful endpoint

Char formation is not evidence of a desirable treatment depth. It can obscure tissue, interfere with assessment, and contribute to heat accumulation during subsequent passes.

The field should be cleared and reassessed before any further treatment is considered.

Understanding the Trade-offs

More passes do not necessarily mean better resurfacing

Additional passes may increase thermal injury faster than they improve the clinical result. Once the target is corrected or the tissue reaches a depth-related warning sign, further treatment can convert a controlled wound into a delayed-healing or scar-forming injury.

The best endpoint is therefore adequate correction with the least necessary thermal exposure.

Visual endpoints have limitations

Color and texture are valuable intraoperative indicators, but they are influenced by lighting, magnification, blood, char, tissue hydration, and operator experience. They should be interpreted together rather than used in isolation.

If tissue appearance is ambiguous, the safer course is to stop, clean the field, reassess, and avoid guessing by delivering another pass.

Device parameters affect the endpoint

Waveform, pulse duration, power or energy, spot size, scan density, and exposure duration all influence ablation and residual thermal damage. These parameters must be selected according to the device’s validated instructions, the indication, and the anatomical site.

A clinical endpoint cannot compensate for unsafe settings, unintended overlap, poor beam control, or inadequate operator training.

Safety monitoring extends beyond skin appearance

Eye protection appropriate to the CO₂ wavelength, flame-resistant drapes, smoke evacuation, and controlled beam activation are essential operating safeguards. These measures prevent ocular injury, fire, and plume exposure but do not replace monitoring of tissue endpoints.

How to Apply This to Your Procedure

Use a conservative, region-specific reassessment after every pass and stop at the earliest applicable endpoint.

If your primary focus is preventing hypertrophic scarring: Stop at faint chamois-yellow coloration or persistent yellow-brown discoloration after cleansing, and do not continue toward deeper reticular dermal injury.
If your primary focus is effective wrinkle or scar correction: Stop when the target is adequately flattened or disappears, because further passes generally add risk without meaningful benefit.
If your primary focus is controlling cumulative heat: Respect the preset pass limit, avoid pulse stacking and overlap, and reassess after clearing char and debris.
If your primary focus is treating thin or sensitive skin: Use fewer passes and apply stricter visual endpoints than you would in thicker regions.
If your primary focus is procedural safety: Combine tissue monitoring with wavelength-specific eye protection, plume evacuation, fire precautions, and validated device settings.

Safe CO₂ laser practice means achieving the intended correction while stopping before tissue injury becomes the endpoint.

Summary Table:

Endpoint	What to Monitor	Action
Target correction	Wrinkle or scar flattening	Stop when adequately corrected
Visible desiccation	Dry tissue appearance	Stop to avoid excessive thermal damage
Chamois-yellow coloration	Faint yellow hue in dermis	Stop to prevent deeper injury
Cessation of contraction	No further tightening	Stop if no additional benefit
Preset pass limit	Number of passes	Stop at limit to control cumulative exposure

Enhance your practice with BELIS's advanced CO2 fractional lasers, designed for precision and safety. Our systems include real-time endpoint monitoring features to help you achieve optimal outcomes while minimizing risks. Contact our experts today to learn more about our FDA-cleared devices, comprehensive training, and dedicated support. Contact us for a personalized consultation tailored to your clinic's needs.